Brokerages Set DocGo Inc. (NASDAQ:DCGO) PT at $6.10

DocGo Inc. (NASDAQ:DCGO) has received an average recommendation of “Buy” from the five brokerages that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the stock in the last year is $6.10.

DCGO has been the topic of several recent research reports. Needham & Company LLC reiterated a “buy” rating and issued a $7.00 price target on shares of DocGo in a report on Thursday, August 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 price target on shares of DocGo in a report on Friday, September 20th.

DocGo Stock Performance

Shares of DCGO stock opened at $3.26 on Friday. The stock’s fifty day moving average is $3.45 and its 200-day moving average is $3.34. The stock has a market capitalization of $331.11 million, a PE ratio of 16.30, a PEG ratio of 2.73 and a beta of 0.91. DocGo has a 52 week low of $2.75 and a 52 week high of $6.90.

DocGo (NASDAQ:DCGO) last announced its earnings results on Wednesday, August 7th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). The business had revenue of $164.95 million for the quarter, compared to the consensus estimate of $166.61 million. DocGo had a return on equity of 8.90% and a net margin of 3.97%. As a group, analysts forecast that DocGo will post 0.23 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DocGo

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. SG Americas Securities LLC boosted its holdings in DocGo by 97.5% during the third quarter. SG Americas Securities LLC now owns 38,147 shares of the company’s stock worth $127,000 after buying an additional 18,835 shares during the last quarter. Point72 Asset Management L.P. raised its position in shares of DocGo by 1,655.7% during the second quarter. Point72 Asset Management L.P. now owns 116,844 shares of the company’s stock worth $361,000 after purchasing an additional 110,189 shares during the period. The Manufacturers Life Insurance Company raised its position in shares of DocGo by 31.6% during the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock worth $125,000 after purchasing an additional 9,696 shares during the period. Marathon Capital Management raised its position in shares of DocGo by 2.3% during the second quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock worth $856,000 after purchasing an additional 6,285 shares during the period. Finally, Deerfield Management Company L.P. Series C raised its position in shares of DocGo by 41.0% during the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock worth $22,236,000 after purchasing an additional 2,091,569 shares during the period. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.